Rare lephants
Screener

SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Mar 16, 2020 FORM 4
4 Mar 16, 2020 FORM 4
4 Mar 16, 2020 FORM 4
4 Mar 16, 2020 FORM 4
4 Mar 16, 2020 FORM 4
4 Mar 16, 2020 FORM 4
4 Mar 16, 2020 FORM 4
S-8 Mar 13, 2020 FORM S-8
8-K Mar 13, 2020 8-K
10-K Mar 13, 2020 10-K
SC 13G/A Feb 14, 2020 SC 13G/A
SC 13G/A Feb 14, 2020 AMENDMENT TO FORM SC 13G
SC 13G/A Feb 13, 2020
SC 13G/A Feb 13, 2020 AMENDMENT NO. 1 TO THE SCHEDULE 13G
SC 13G Jan 17, 2020 SC 13G
424B5 Jan 10, 2020 424B5
8-K Jan 10, 2020 FORM 8-K
8-K Jan 7, 2020 FORM 8-K
8-K Nov 25, 2019 8-K
8-K Nov 14, 2019 8-K
10-Q Nov 14, 2019 10-Q
8-K Nov 6, 2019 FORM 8-K
8-K Oct 31, 2019 FORM 8-K
424B5 Oct 30, 2019 424B5
EFFECT Oct 11, 2019
← Newer Page 12 of 51 · 1272 filings Older →